As shown in Fig. 1, VCAM-1 was significantly elevated in the PAD group (median 953 ng/ml in controls, IQR 812-1218 vs. 1352 ng/ml, IQR 1112-1569 in PAD patients, p < 0.0001). This evidence concerns the gene VCAM1 and peripheral arterial disease.